| Model Number |
FX826T |
| Medical Device Problem Codes |
Mechanical Problem (1384); Infusion or Flow Problem (2964)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
07/02/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Manufacturing site evaluation: investigation on-going.As soon as we have examined the product, a supplemental medwatch report will be submitted.
|
| |
|
Event or Problem Description
|
|
It was reported that an m.Blue 5 (#fx826t) was implanted during a procedure performed on (b)(6) 2024.According to the complainant, the shunt system showed an under-drainage and adjustment difficulties.The patient underwent a revision procedure performed on (b)(6) 2024.The complainant device has returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 64 years, as soon as we have examined the product, a supplemental medwatch report will be submitted.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual inspection: during the investigation, no significant deformations or damage of the valve were determined.Permeability test: a permeability test has shown that all components are permeable.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the valves operate within the permissible tolerance in their respective relevant positions.Adjustment test: the m.Blue was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerances.Internal inspection: after dismantling of the valve, deposits were found inside.Results: based on our investigation results, we can determine visible deposits.The deposits had no effect upon the specifications at the time of the examination.At the time of the examination, it is not clear to us how the abovementioned functional impairment occurred.Organic material in the csf can temporarily influence the function and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
| |
|
Search Alerts/Recalls
|